Is It Safe to Take 650 mg of Paracetamol on a Regular Basis?

Sunil   Kumar   Kadiri; Deepika      Uchil; Dhani   Movuram   Guruprakash; Dhritija      Sathavalli; Durgesh      Singh
Abstract

The commonest medication to treat moderate to severe pain and fever in adults and children is paracetamol and it has been observed that there is a rapid increase in the intake of paracetamol- 650 since the COVID-19 pandemic and it is continuing till date. This analgesic and antipyretic medication showed an increase of 150% in its consumption during the pandemic, simultaneously escalating its self-medication. Concerns have been expressed about the indirect advertising of prescription medications, their illogical use, and improper self-medication, which has resulted in overdose and certain serious side effects. Chronic pain and pyrexia are the most common symptoms witnessed during the COVID-19 pandemic. The intake of paracetamol-650 has also been increased as a prophylactic measure due to the widespread fear generated during COVID-19. The usage of paracetamol has been shifted from 500 mg to 650 mg for mild and moderate pain and fever during and after the end of the pandemic. This raises concerns about the misuse of paracetamol-650mg which may cause damage to the liver, stomach, and kidney chronically. So, this review article aims to generate awareness among the public and physicians about the rationale of paracetamol as an analgesic and antipyretic.
Keywords: Paracetamol-650, COVID-19, analgesic, anti-pyretic, overdose, pandemic, prophylactic.
Graphical Abstract

[1]
Eccles R. Efficacy and safety of over-the-counter analgesics in the treatment of common cold and flu. J Clin Pharm Ther  2006; 31(4): 309-19.
 [http://dx.doi.org/10.1111/j.1365-2710.2006.00754.x ] [PMID:  16882099]

[2]
Lesko SM, Mitchell AA. An assessment of the safety of pediatric ibuprofen. A practitioner-based randomized clinical trial. JAMA  1995; 273(12): 929-33.
 [http://dx.doi.org/10.1001/jama.1995.03520360043037 ] [PMID:  7884951]

[3]
Ulukol B, Köksal Y, Cin S. Assessment of the efficacy and safety of paracetamol, ibuprofen and nimesulide in children with upper respiratory tract infections. Eur J Clin Pharmacol  1999; 55(9): 615-8.
 [http://dx.doi.org/10.1007/s002280050681 ] [PMID:  10638387]

[4]
Miners JO, Penhall R, Robson RA, Birkett DJ. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol  1988; 35(2): 157-60.
 [http://dx.doi.org/10.1007/BF00609245 ] [PMID:  3191934]

[5]
Hudgings L, Kelsberg G, Safranek S, Neher JO. Clinical inquiries. Do antipyretics prolong febrile illness? J Fam Pract  2004; 53(1): 57-58, 61.
 [PMID:  14709270]

[6]
Graham NMH, Burrell CJ, Douglas RM, Debelle P, Davies L. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis  1990; 162(6): 1277-82.
 [http://dx.doi.org/10.1093/infdis/162.6.1277 ] [PMID:  2172402]

[7]
Schachtel BP, Fillingim JM, Beiter DJ, Lane AC, Schwartz LA. Rating scales for analgesics in sore throat. Clin Pharmacol Ther  1984; 36(2): 151-6.
 [http://dx.doi.org/10.1038/clpt.1984.154 ] [PMID:  6744773]

[8]
Schachtel BP, Fillingim JM, Lane AC, Thoden WR, Baybutt RI. Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat. Arch Intern Med  1991; 151(4): 733-7.
 [http://dx.doi.org/10.1001/archinte.1991.00400040081017 ] [PMID:  2012456]

[9]
Eccles R, Loose I, Jawad M, Nyman L. Effects of acetylsalicylic acid on sore throat pain and other pain symptoms associated with acute upper respiratory tract infection. Pain Med  2003; 4(2): 118-24.
 [http://dx.doi.org/10.1046/j.1526-4637.2003.03019.x ] [PMID:  12873261]

[10]
Edwards JE, Oldman A, Smith L, et al. Single dose oral aspirin for acute pain. Cochrane Database Syst Rev  2000; (2): CD002067.
 [PMID:  10796855]

[11]
Younkin SW, Betts RF, Roth FK, Douglas RG Jr. Reduction in fever and symptoms in young adults with influenza A/Brazil/78 H1N1 infection after treatment with aspirin or amantadine. Antimicrob Agents Chemother  1983; 23(4): 577-82.
 [http://dx.doi.org/10.1128/AAC.23.4.577 ] [PMID:  6859836]

[12]
Milvio C. Treatment of influenza syndrome. A double-blind controlled trial of nimesulide v. aspirin. Clin Trials J  1985; 22(1): 111-7.

[13]
Bachert C, Chuchalin AG, Eisebitt R, Netayzhenko VZ, Voelker M. Aspirin compared with acetaminophen in the treatment of fever and other symptoms of upper respiratory tract infection in adults: A multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-dose, 6-hour dose-ranging study. Clin Ther  2005; 27(7): 993-1003.
 [http://dx.doi.org/10.1016/j.clinthera.2005.06.002 ] [PMID:  16154478]

[14]
Colgan MT, Mintz AA. The comparative antipyretic effect of N-acetyl-p-aminophenol and acetylsalicylic acid. J Pediatr  1957; 50(5): 552-5.
 [http://dx.doi.org/10.1016/S0022-3476(57)80219-4 ] [PMID:  13417020]

[15]
Yaffe SJ. Comparative efficacy of aspirin and acetaminophen in the reduction of fever in children. Arch Intern Med  1981; 141(3): 286-92.
 [http://dx.doi.org/10.1001/archinte.1981.00340030018005 ] [PMID:  7008732]

[16]
Prescott LF. Paracetamol. Am J Ther  2000; 7(2): 143-8.
 [http://dx.doi.org/10.1097/00045391-200007020-00011 ] [PMID:  11319582]

[17]
Melis R. Ibuprofen and/or acetaminophen: What price for “euthermia”? J Pediatr  1997; 131(2): 332.
 [http://dx.doi.org/10.1016/S0022-3476(97)70179-3 ] [PMID:  9290629]

[18]
Cooper SA. Comparative analgesic efficacies of aspirin and acetaminophen. Arch Intern Med  1981; 141(3): 282-5.
 [http://dx.doi.org/10.1001/archinte.1981.00340030014004 ] [PMID:  7008731]

[19]
Peters BH, Fraim CJ, Masel BE. Comparison of 650 mg aspirin and 1,000 mg acetaminophen with each other, and with placebo in moderately severe headache. Am J Med  1983; 74(6): 36-42.
 [http://dx.doi.org/10.1016/0002-9343(83)90526-0 ] [PMID:  6344625]

[20]
Clissold SP. Paracetamol and phenacetin. Drugs  1986; 32(S4): 46-59.
 [http://dx.doi.org/10.2165/00003495-198600324-00005 ] [PMID:  3552585]

[21]
Perrott DA, Piira T, Goodenough B, Champion GD. Efficacy and safety of acetaminophen vs ibuprofen for treating children’s pain or fever: A meta-analysis. Arch Pediatr Adolesc Med  2004; 158(6): 521-6.
 [http://dx.doi.org/10.1001/archpedi.158.6.521 ] [PMID:  15184213]

[22]
Pandolfi S, Chirumbolo S, Ricevuti G, et al. Home pharmacological therapy in early COVID‐19 to prevent hospitalization and reduce mortality: Time for a suitable proposal. Basic Clin Pharmacol Toxicol  2022; 130(2): 225-39.
 [http://dx.doi.org/10.1111/bcpt.13690 ] [PMID:  34811895]

[23]
Romano S, Galante H, Figueira D, Mendes Z, Rodrigues AT. Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies. Res Social Adm Pharm  2021; 17(1): 1876-81.
 [http://dx.doi.org/10.1016/j.sapharm.2020.05.024 ] [PMID:  32482587]

[24]
Lu X, Zhang L, Du H, et al. SARS-CoV-2 infection in children. N Engl J Med  2020; 382(17): 1663-5.
 [http://dx.doi.org/10.1056/NEJMc2005073 ] [PMID:  32187458]

[25]
Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med  2020; 382(18): 1708-20.
 [http://dx.doi.org/10.1056/NEJMoa2002032 ] [PMID:  32109013]

[26]
Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild‐to‐moderate coronavirus disease 2019. J Intern Med  2020; 288(3): 335-44.
 [http://dx.doi.org/10.1111/joim.13089 ] [PMID:  32352202]

[27]
Duong M, Gulmez SE, Salvo F, et al. Usage patterns of paracetamol in France. Br J Clin Pharmacol  2016; 82(2): 498-503.
 [http://dx.doi.org/10.1111/bcp.12957 ] [PMID:  27059520]

[28]
Diener HC, Schneider R, Aicher B. Per-capita consumption of analgesics: A nine-country survey over 20 years. J Headache Pain  2008; 9(4): 225-31.
 [http://dx.doi.org/10.1007/s10194-008-0046-6 ] [PMID:  18618072]

[29]
Shader RI. Acetaminophen (paracetamol), COVID-19, and misleading conclusions: A commentary. J Clin Psychopharmacol  2021; 41(2): 98-9.
 [http://dx.doi.org/10.1097/JCP.0000000000001345 ] [PMID:  33443969]

[30]
Keaveney A, Peters E, Way B. Effects of acetaminophen on risk taking. Soc Cogn Affect Neurosci  2020; 15(7): 725-32.
 [http://dx.doi.org/10.1093/scan/nsaa108 ] [PMID:  32888031]

[31]
Rodríguez-Morales AJ, Cardona-Ospina JA, Murillo-Muñoz MM. Gastroenterologists, hepatologists, COVID-19 and the use of acetaminophen. Clin Gastroenterol Hepatol  2020; 18(9): 2142-3.
 [http://dx.doi.org/10.1016/j.cgh.2020.04.025 ] [PMID:  32387226]

[32]
Peluso L, Abella BS, Ferrer R, Kucher N, Sunde K, Taccone FS. Fever management in COVID-19 patients. Minerva Anestesiol  2021; 87(1): 1-3.
 [http://dx.doi.org/10.23736/S0375-9393.20.15195-2 ] [PMID:  33231411]

[33]
Robertson JA, Sauer D, Gold JA, Nonas SA. The role of cyclooxygenase-2 in mechanical ventilation-induced lung injury. Am J Respir Cell Mol Biol  2012; 47(3): 387-94.
 [http://dx.doi.org/10.1165/rcmb.2011-0005OC ] [PMID:  22556158]

[34]
Zand Irani A, Borchert G, Craven B, Gibbons H. Flucloxacillin and paracetamol induced pyroglutamic acidosis. BMJ Case Rep  2021; 14(1): e237536.
 [http://dx.doi.org/10.1136/bcr-2020-237536 ] [PMID:  33419747]

[35]
Mendoza CD, Heard K, Dart RC. Coma, metabolic acidosis and normal liver function in a child with a large serum acetaminophen level. Ann Emerg Med  2006; 48(5): 637.
 [http://dx.doi.org/10.1016/j.annemergmed.2006.06.045 ] [PMID:  17052573]

[36]
Steiner AA. Should we let fever run its course in the early stages of COVID-19? J R Soc Med  2020; 113(10): 407-9.
 [http://dx.doi.org/10.1177/0141076820951544 ] [PMID:  32930066]

[37]
Hodgman MJ, Garrard AR. A review of acetaminophen poisoning. Crit Care Clin  2012; 28(4): 499-516.
 [http://dx.doi.org/10.1016/j.ccc.2012.07.006 ] [PMID:  22998987]

[38]
Sharma O, Sultan AA, Ding H, Triggle CR. A review of the progress and challenges of developing a vaccine for COVID-19. Front Immunol  2020; 11: 585354.
 [http://dx.doi.org/10.3389/fimmu.2020.585354 ] [PMID:  33163000]

[39]
Quaglietta L, Martinelli M, Staiano A. Serious infectious events and ibuprofen administration in pediatrics: A narrative review in the era of COVID-19 pandemic. Ital J Pediatr  2021; 47(1): 20.
 [http://dx.doi.org/10.1186/s13052-021-00974-0 ] [PMID:  33514404]

[40]
Ramakrishnan S, Nicolau DV Jr, Langford B, et al. Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. Lancet Respir Med  2021; 9(7): 763-72.
 [http://dx.doi.org/10.1016/S2213-2600(21)00160-0 ] [PMID:  33844996]

[41]
Wojcieszyńska D, Guzik H, Guzik U. Non-steroidal anti-inflammatory drugs in the era of the COVID-19 pandemic in the context of the human and the environment. Sci Total Environ  2022; 834: 155317.
 [http://dx.doi.org/10.1016/j.scitotenv.2022.155317 ] [PMID:  35452725]

[42]
Ragni E, Mangiavini L, Viganò M, et al. Management of osteoarthritis during the COVID‐19 pandemic. Clin Pharmacol Ther  2020; 108(4): 719-29.
 [http://dx.doi.org/10.1002/cpt.1910 ] [PMID:  32438454]

[43]
Simnani FZ, Singh D, Kaur R. COVID-19 phase 4 vaccine candidates, effectiveness on SARS-CoV-2 variants, neutralizing antibody, rare side effects, traditional and nano-based vaccine platforms: A review. 3 Biotech  2022; 12(1): 15.

[44]
Pandolfi S, Valdenassi L, Bjørklund G, et al. COVID-19 medical and pharmacological management in the European countries compared to Italy: An overview. Int J Environ Res Public Health  2022; 19(7): 4262.
 [http://dx.doi.org/10.3390/ijerph19074262 ] [PMID:  35409942]

[45]
Aouissi HA, Belhaouchet I. What about rheumatic diseases and COVID-19? New Microbes New Infect  2021; 41: 100846.
 [http://dx.doi.org/10.1016/j.nmni.2021.100846 ] [PMID:  33614039]

[46]
De Sarro C, Papadopoli R, Morgante MC, Nobile CGA, De Sarro G, Pileggi C. Vaccinations status against vaccine-preventable diseases and willingness to be vaccinated in an italian sample of frail subjects. Vaccines  2022; 10(8): 1311.
 [http://dx.doi.org/10.3390/vaccines10081311 ] [PMID:  36016199]

[47]
Iguacel I, Maldonado AL, Ruiz-Cabello AL, Casaus M, Moreno LA, Martínez-Jarreta B. Association between COVID-19 vaccine side effects and body mass index in Spain. Vaccines  2021; 9(11): 1321.
 [http://dx.doi.org/10.3390/vaccines9111321 ] [PMID:  34835252]

[48]
Dimova S, Hoet PHM, Dinsdale D, Nemery B. Acetaminophen decreases intracellular glutathione levels and modulates cytokine production in human alveolar macrophages and type II pneumocytes in vitro. Int J Biochem Cell Biol  2005; 37(8): 1727-37.
 [http://dx.doi.org/10.1016/j.biocel.2005.03.005 ] [PMID:  15878691]

[49]
Geddes L. The fever paradox. New Sci  2020; 246(3277): 39-41.
 [http://dx.doi.org/10.1016/S0262-4079(20)30731-4 ] [PMID:  32372807]

[50]
Egeberg O. The effect of unspecific fever induction on the blood clotting system. Scand J Clin Lab Invest  1962; 14(5): 471-4.
 [http://dx.doi.org/10.3109/00365516209051265]

[51]
Campbell RA, Boilard E, Rondina MT. Is there a role for the ACE2 receptor in SARS‐CoV‐2 interactions with platelets? J Thromb Haemost  2021; 19(1): 46-50.
 [http://dx.doi.org/10.1111/jth.15156 ] [PMID:  33119197]

[52]
Shen S, Zhang J, Fang Y, et al. SARS-CoV-2 interacts with platelets and megakaryocytes via ACE2-independent mechanism. J Hematol Oncol  2021; 14(1): 72.
 [http://dx.doi.org/10.1186/s13045-021-01082-6 ] [PMID:  33926500]

[53]
Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Prehospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: A population-based cohort study. Chest  2011; 139(2): 289-95.
 [http://dx.doi.org/10.1378/chest.10-0891 ] [PMID:  20688925]

[54]
Munsterhjelm E, Munsterhjelm NM, Niemi TT, Ylikorkala O, Neuvonen PJ, Rosenberg PH. Dose-dependent inhibition of platelet function by acetaminophen in healthy volunteers. Anesthesiology  2005; 103(4): 712-7.
 [http://dx.doi.org/10.1097/00000542-200510000-00009 ] [PMID:  16192763]

[55]
Munsterhjelm E, Niemi TT, Ylikorkala O, Silvanto M, Rosenberg PH. Characterization of inhibition of platelet function by paracetamol and its interaction with diclofenac in vitro. Acta Anaesthesiol Scand  2005; 49(6): 840-6. b
 [http://dx.doi.org/10.1111/j.1399-6576.2005.00707.x] [PMID: 15954969]

[56]
Ghaffar UB, Tadvi NA. Paracetamol toxicity: A review. J Contemp Med Dent  2014; 2: 12-5.

[57]
Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics  2001; 108(3): e52.
 [http://dx.doi.org/10.1542/peds.108.3.e52 ] [PMID:  11533370]

[58]
Smith W, Leyva R, Kellstein D, Arthur E, Cruz-Rivera M. Efficacy of a fixed-dose combination of ibuprofen and acetaminophen compared with individual monocomponents in adult male subjects with endotoxin-induced fever: A randomized controlled trial. Clin Ther  2021; 43(7): 1213-27.
 [http://dx.doi.org/10.1016/j.clinthera.2021.05.004 ] [PMID:  34304913]

[59]
Ooi EE, Dhar A, Petruschke R, Locht C, Buchy P, Low JG. Use of analgesics/antipyretics in the management of symptoms associated with COVID-19 vaccination. npj. Vaccines  2022; 7(1): 31.
 [PMID:  36679876]

[60]
Warwick C. Paracetamol and fever management. J R Soc Promot Health  2008; 128(6): 320-3.
 [http://dx.doi.org/10.1177/1466424008092794 ] [PMID:  19058473]

[61]
Kingsley Ogemdi I. A Review on the Properties and Uses of Paracetamol. Int J Pharm Chem  2019; 5(3): 31-5.
 [http://dx.doi.org/10.11648/j.ijpc.20190503.12]

[62]
Sharma CV, Mehta V. Paracetamol: Mechanisms and updates. Contin Educ Anaesth Crit Care Pain  2014; 14(4): 153-8.
 [http://dx.doi.org/10.1093/bjaceaccp/mkt049]

[63]
Manna S, Tripathy S, Dor VJ, Padhi BK. Paracetamol usages regulation: A need of the hour. Ann Med Surg  2022; 84(Dec): 104805.
 [http://dx.doi.org/10.1016/j.amsu.2022.104805 ] [PMID:  36387958]

[64]
McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ. Long‐term adverse effects of paracetamol – a review. Br J Clin Pharmacol  2018; 84(10): 2218-30.
 [http://dx.doi.org/10.1111/bcp.13656 ] [PMID:  29863746]

[65]
Nilsen K, Staff AC, Krogsrud SK. Paracetamol use in pregnancy: Not as safe as we may think? Acta Obstet Gynecol Scand  2023; 102(6): 652-6.
 [http://dx.doi.org/10.1111/aogs.14557 ] [PMID:  36941046]

[66]
Turtle EJ, Dear JW, Webb DJ. A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol  2013; 75(6): 1396-405.
 [http://dx.doi.org/10.1111/bcp.12032 ] [PMID:  23145789]

[67]
Conaghan PG, Arden N, Avouac B, Migliore A, Rizzoli R. Safety of paracetamol in osteoarthritis: What does the literature say? Drugs Aging  2019; 36(S1): 7-14.
 [http://dx.doi.org/10.1007/s40266-019-00658-9 ] [PMID:  31073920]

[68]
Offor SJ, Amadi CN, Chijioke-Nwauche I, Manautou JE, Orisakwe OE. Potential deleterious effects of paracetamol dose regime used in Nigeria versus that of the United States of America. Toxicol Rep  2022; 9: 1035-44.
 [http://dx.doi.org/10.1016/j.toxrep.2022.04.025 ] [PMID:  36561959]

[69]
Ali I, Alharbi OML. COVID-19: Disease, management, treatment, and social impact. Sci Total Environ  2020; 728: 138861.
 [http://dx.doi.org/10.1016/j.scitotenv.2020.138861 ] [PMID:  32344226]

[70]
Mattiuzzi C, Lippi G. How much has COVID-19 contributed to increase the worldwide consumption of paracetamol and ibuprofen? evidence from an infodemiological analysis. Hosp Pharm 2022.
 [PMID:  36644739]

[71]
Saleh EA, Haddadin RN, Saleh B, Elayeh E. Changes in drug demand when a pandemic coincides with other outbreaks in a war zone country: A cross-sectional pilot study. J Pharm Policy Pract  2022; 15(1): 89.
 [http://dx.doi.org/10.1186/s40545-022-00487-z ] [PMID:  36419090]

[72]
Przybyła GW, Szychowski KA, Gmiński J. Paracetamol – An old drug with new mechanisms of action. Clin Exp Pharmacol Physiol  2021; 48(1): 3-19.
 [http://dx.doi.org/10.1111/1440-1681.13392 ] [PMID:  34545616]

[73]
Pandolfi S, Simonetti V, Ricevuti G, Chirumbolo S. Paracetamol in the home treatment of early COVID‐19 symptoms: A possible foe rather than a friend for elderly patients? J Med Virol  2021; 93(10): 5704-6.
 [http://dx.doi.org/10.1002/jmv.27158 ] [PMID:  34170556]

[74]
Mostafa EMA, Tawfik AM, Abd-Elrahman KM. Egyptian perspectives on potential risk of paracetamol/acetaminophen-induced toxicities: Lessons learnt during COVID-19 pandemic. Toxicol Rep  2022; 9: 541-8.
 [http://dx.doi.org/10.1016/j.toxrep.2022.03.035 ] [PMID:  35371923]

[75]
Mir SA, Shakeel D, Qadri ZL. Self-medication practices during COVID-19 pandemic: A cross-sectional survey. Asian J Pharm Clin Res  2021; 29(1): 80-2.

[76]
Patel PA, Zalavadia J, Prajapati A, et al. Self-medication among medical students during the COVID19 pandemic. Natl J Community Med  2023; 14(5): 335-9.
 [http://dx.doi.org/10.55489/njcm.140520232855]

[77]
Ambali AP, Santhosh BT. The safety profile of COVID-19 Vaccination among 1373 elderly population. Medica  2022; 11(1): 7.

[78]
Roy SP, Kadiri SK, Karkar VV, Konijeti SR. Antiparkinsonian activity of Tabebuiaimpetiginosa bark and biochemical analysis of dopamine in rat brain homogenates. Ann Pharm Fr  2022; 80(6): 853-63.

[79]
Damani A, Ghoshal A, Salins N, et al. Approaches and best practices for managing cancer pain within the constraints of the COVID-19 pandemic in India. Indian J Palliat Care  2020; 26(S1): S106-15.
 [PMID:  33088099]

[80]
Jethi N, Banik S, Yadav P, Kaur S, Kaur K, Ratani KA. Post obturation analgesia in patients recently vaccinated against Covid-19, after Root canal treatment: a short observational study. Eur J Mol Clin Med  2022; 9(07)

[81]
Singh S, Kishore D, Singh RK. Potential for further mismanagement of fever during COVID-19 pandemic: Possible causes and impacts. Front Med  2022; 9: 751929.
 [http://dx.doi.org/10.3389/fmed.2022.751929 ] [PMID:  35308547]

[82]
Panse S, Kanchi M, Chacko J. Intensive care unit setup for COVID-19. J Cardiac Crit Care TSS  2020; 4(01): 05-11.

[83]
Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med  2020; 382(10): 929-36.
 [http://dx.doi.org/10.1056/NEJMoa2001191 ] [PMID:  32004427]

[84]
Priya S, Sindhushavishwanatha S, Kadiri SK, Mallik A. survey on prophylactic measures taken by the hyderabadi’s during the 2nd wave of COVID-19. Int J Health Sci  2022; 6(S2): 13824-40.
 [http://dx.doi.org/10.53730/ijhs.v6nS2.8849]

[85]
Sevella P, Rallabhandi SSH, Jahagirdar V, et al. Acute mesenteric ischemia as an early complication of COVID-19. Cureus  2021; 13(9): e18082.
 [http://dx.doi.org/10.7759/cureus.18082 ] [PMID:  34671542]

[86]
Amawi H, Abu Deiab GI, A Aljabali AA, Dua K, Tambuwala MM. COVID-19 pandemic: An overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv  2020; 11(4): 245-68.
 [http://dx.doi.org/10.4155/tde-2020-0035 ] [PMID:  32397911]

[87]
PATEL H, Makwana H, Shah K, Malhotra S. Transient liver enzyme derangement following Remdesivir use: A case series. J Pharmacovigil Drug Saf  2021; 2(3): 30-4.

[88]
Bianconi V, Violi F, Fallarino F, Pignatelli P, Sahebkar A, Pirro M. Is acetylsalicylic acid a safe and potentially useful choice for adult patients with COVID-19? Drugs  2020; 80(14): 1383-96.
 [http://dx.doi.org/10.1007/s40265-020-01365-1 ] [PMID:  32705604]

[89]
Vanden Eynde JJ. COVID-19: A brief overview of the discovery clinical trial. Pharmaceuticals  2020; 13(4): 65.
 [http://dx.doi.org/10.3390/ph13040065 ] [PMID:  32290348]

[90]
Sestili P, Fimognari C. Paracetamol-induced glutathione consumption: is there a link with severe COVID-19 illness? Front Pharmacol  2020; 11: 579944.
 [http://dx.doi.org/10.3389/fphar.2020.579944 ] [PMID:  33117175]

[91]
Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol  2016; 81(2): 210-22.
 [http://dx.doi.org/10.1111/bcp.12802 ] [PMID:  26460177]

[92]
Amar PJ, Schiff ER. Acetaminophen safety and hepatotoxicity – where do we go from here? Expert Opin Drug Saf  2007; 6(4): 341-55.
 [http://dx.doi.org/10.1517/14740338.6.4.341 ] [PMID:  17688378]

[93]
Mitchell RA, Rathi S, Dahiya M, Zhu J, Hussaini T, Yoshida EM. Public awareness of acetaminophen and risks of drug induced liver injury: Results of a large outpatient clinic survey. PLoS One  2020; 15(3): e0229070.
 [http://dx.doi.org/10.1371/journal.pone.0229070 ] [PMID:  32130228]

[94]
Shek KLA, Chan LN, Nutescu E. Warfarin-acetaminophen drug interaction revisited. Pharmacotherapy  1999; 19(10): 1153-8.
 [http://dx.doi.org/10.1592/phco.19.15.1153.30584 ] [PMID:  10512064]

[95]
Lee WM. Acetaminophen (APAP) hepatotoxicity—Isn’t it time for APAP to go away? J Hepatol  2017; 67(6): 1324-31.
 [http://dx.doi.org/10.1016/j.jhep.2017.07.005 ] [PMID:  28734939]

[96]
Schweighardt AE, Juba KM. A systematic review of the evidence behind use of reduced doses of acetaminophen in chronic liver disease. J Pain Palliat Care Pharmacother  2018; 32(4): 226-39.
 [http://dx.doi.org/10.1080/15360288.2019.1611692 ] [PMID:  31206302]

[97]
Penna A, Buchanan N. Paracetamol poisoning in children and hepatotoxicity. Br J Clin Pharmacol  1991; 32(2): 143-9.
 [http://dx.doi.org/10.1111/j.1365-2125.1991.tb03873.x ] [PMID:  1931463]

[98]
Use antipyretics for at-home management of children with low-risk fever and distress. Drugs Ther Perspect  2014; 30(12): 422-5.
 [http://dx.doi.org/10.1007/s40267-014-0166-9]

[99]
Khan UD. My journey through untested COVID-19. Anaesth Pain Intensive Care  2020; 24(2): 252.
 [http://dx.doi.org/10.35975/apic.v24i2.1272]

[100]
Shah S. COVID-19 and paediatric dentistry-traversing the challenges. A narrative review. Ann Med Surg  2020; 58: 22-33.
 [http://dx.doi.org/10.1016/j.amsu.2020.08.007 ] [PMID:  32864126]

[101]
Pountoukidou A, Potamiti-Komi M, Sarri V, et al. Management and prevention of COVID-19 in pregnancy and pandemic obstetric care: A review of current practices. Healthcare  2021; 9(4): 467.

[102]
Seirafianpour F, Sodagar S, Pour Mohammad A, et al. Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review. Dermatol Ther  2020; 33(6): e13986.
 [http://dx.doi.org/10.1111/dth.13986 ] [PMID:  32639077]

[103]
Erku DA, Belachew SA, Abrha S, et al. When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the ‘infodemic’ surrounding COVID-19. Res Social Adm Pharm  2021; 17(1): 1954-63.
 [http://dx.doi.org/10.1016/j.sapharm.2020.04.032 ] [PMID:  32387230]

[104]
Kabwe JC, Lubeya MK, Phiri CC, et al. Psychosocial issues and coping mechanisms of pregnant and postnatal women diagnosed with COVID-19: A qualitative study. Womens Health  2022; 18.
 [http://dx.doi.org/10.1177/17455057221111326 ] [PMID:  35838184]

[105]
Bhamra SK, Parmar J, Heinrich M. Impact of the coronavirus pandemic (COVID-19) on the professional practice and personal well-being of community pharmacy teams in the UK. Int J Pharm Pract  2021; 29(6): 556-65.
 [http://dx.doi.org/10.1093/ijpp/riab062 ] [PMID:  34605895]

[106]
Mansfield KE, Mathur R, Tazare J, et al. Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: A population-based study. Lancet Digit Health  2021; 3(4): e217-30.
 [http://dx.doi.org/10.1016/S2589-7500(21)00017-0 ] [PMID:  33612430]
Cite As
Coronaviruses

Is It Safe to Take 650 mg of Paracetamol on a Regular Basis?

Abstract

Graphical Abstract
